$30.6 Million is the total value of Mass General Brigham, Inc's 1 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGG | Exit | ISHARES CORE U.S. AGGREGATEetf | $0 | – | -654,083 | -100.0% | -100.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-01-24
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COINBASE GLOBAL INC CLASS A | 12 | Q1 2024 | 89.8% |
ISHARES CORE U.S. AGGREGATE ETF | 10 | Q1 2021 | 100.0% |
ISHARES CORE SP 500 ETF | 9 | Q2 2023 | 57.8% |
ISHARES CORE U.S. AGGREGATE ETF | 9 | Q2 2023 | 40.5% |
ISHARES MSCI ACWI ETF | 8 | Q1 2021 | 100.0% |
ISHARES CORE SP 500 ETF | 7 | Q1 2021 | 100.0% |
REVOLUTION MEDICINES INC | 4 | Q2 2024 | 63.9% |
RIVIAN AUTOMOTIVE INC | 3 | Q3 2023 | 10.2% |
FULCRUM THERAPEUTICS INC | 3 | Q2 2024 | 6.2% |
PLIANT THERAPEUTICS INC | 2 | Q2 2024 | 15.1% |
View Mass General Brigham, Inc's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-07-31 |
13F-HR | 2024-04-04 |
13F-HR | 2024-01-24 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-05 |
13F-HR | 2023-01-19 |
13F-HR | 2022-10-19 |
13F-HR | 2022-07-27 |
13F-HR | 2022-04-15 |
View Mass General Brigham, Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.